Qinglin Li

4.0k citations
86 papers · 3.3k indexed · 1 hit paper · h-index 31
Topics
Cancer-related molecular mechanisms research (16 papers)Natural Compound Pharmacology Studies (8 papers)Natural product bioactivities and synthesis (7 papers)
Partner nations
ChinaUnited StatesMacao

In The Last Decade

Qinglin Li

79 papers receiving 3.2k citations

Hit Papers

Beclin1-binding UVRAG targets the class C Vps complex to ...20082026201420202008200400600

Peers

Qinglin Li
Comparison fields: 5 of 119
  • Molecular Biology 1.7k
  • Cancer Research 681
  • Epidemiology 668
  • Pharmacology 347
  • Plant Science 341
Replace Yao Shen with:
Yao Shen China
Qian Yang China
Hong‐Seob So South Korea
Jieqiong Tan China
Daniela De Zio Denmark
Liping Chen China
Alfeu Zanotto‐Filho Brazil
Consuelo Amantini Italy
Roberta Ricciarelli Italy
Young J. Oh South Korea
Qinglin Li relative to Yao Shen China Yao Shen's profile →
Citations per field
00.5×2.9×
Yao Shen · 1×
Citations per year

Countries citing papers authored by Qinglin Li

Since Specialization
Citations

This map shows the geographic impact of Qinglin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglin Li more than expected).

Fields of papers citing papers by Qinglin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglin Li. The network helps show where Qinglin Li may publish in the future.

Co-authorship network of co-authors of Qinglin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglin Li. A scholar is included among the top collaborators of Qinglin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglin Li. Qinglin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 0
6 2
7 9
8 10
9 5
10 6
11 4
12 36
13 69
14 23
15 208
16
Gastrodin Protects PC12 Cells from Glutamate Toxicity by Down-regulating ERK1/2 and p38 Pathways
1
17
Gambogenic acid induced apoptosis in human nasopharyngeal carcinoma CNE-1 cells and effect of p-p38 and p-ERK1/2 protein
1
18 68
19
Antitumor effects of neogambogic acid both in vivo and in vitro
3
20 80

About Qinglin Li

Qinglin Li is a scholar working on Cancer Research, Geriatrics and Gerontology and Neurology, having authored 86 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (16 papers), Natural Compound Pharmacology Studies (8 papers) and Natural product bioactivities and synthesis (7 papers). The work is most often cited by research in Cancer Research (681 citations), Physiology (164 citations) and Complementary and alternative medicine (203 citations). Qinglin Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xuncui Wang, Guoqi Zhu, Gabriel Eades, Yuan Yao, Yongshu Zhang, Esteban A. Roberts, Chihiro Akazawa, Chengyu Liang, Vojo Deretić and Kyung‐Soo Inn. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026